NCT06199752View on ClinicalTrials.gov

Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 12, 2021

Primary Completion Date

April 20, 2023

Study Completion Date

September 10, 2023

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
DIETARY_SUPPLEMENT

probiotic agent 25 Billion CFU (Nowfoods, USA) , ). Inulin capsules 1000mg Herbamama USA

probiotic agent 25 Billion CFU (Nowfoods, USA), composed of ten strains of bacteria (Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantaLactobacillus paracasei, Bifidobacterium breve, Streotococcus thermophiles, Lactobacillus salivarius, and Bifidobacterium longum),

Trial Locations (1)

12411

Sara Maher, Cairo

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER

NCT06199752 - Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter